These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19719417)

  • 1. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
    Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2019.
    Coombs GW; Daley DA; Mowlaboccus S; Pang S;
    Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Bigseth RS; Sandholdt H; Petersen A; Østergaard C; Benfield T; Thorlacius-Ussing L
    Microbiol Spectr; 2022 Jun; 10(3):e0153021. PubMed ID: 35438533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
    Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
    J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
    Lesse AJ; Mylotte JM
    Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
    Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD;
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Community-Onset
    Yarovoy JY; Monte AA; Knepper BC; Young HL
    West J Emerg Med; 2019 May; 20(3):438-442. PubMed ID: 31123543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.
    Kaasch AJ; Rieg S; Kuetscher J; Brodt HR; Widmann T; Herrmann M; Meyer C; Welte T; Kern P; Haars U; Reuter S; Hübner I; Strauss R; Sinha B; Brunkhorst FM; Hellmich M; Fätkenheuer G; Kern WV; Seifert H;
    Infection; 2013 Oct; 41(5):979-85. PubMed ID: 23539143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
    Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
    J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains.
    Jokinen E; Laine J; Huttunen R; Rahikka P; Huhtala H; Vuento R; Vuopio J; Syrjänen J
    Infect Dis (Lond); 2017 Jul; 49(7):493-500. PubMed ID: 28276799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
    Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
    Trials; 2015 Oct; 16():450. PubMed ID: 26452342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
    Lodise TP; McKinnon PS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):113-22. PubMed ID: 15964499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.